Caprion Biosciences acquires California─based biomarker & immune monitoring provider Primity Bio

14:37 EDT 23 Aug 2018 | PharmaBiz

Caprion Biosciences announced that the company acquired Primity Bio Inc., a specialized provider of biomarker and immune monitoring services located in Fremont, California. Caprion will leverage Primity's strong

More From BioPortfolio on "Caprion Biosciences acquires California─based biomarker & immune monitoring provider Primity Bio"